Foresite Capital Management Iv, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Foresite Capital Management Iv, Llc disclosed 6 stock positions valued at approximately $290.15M as of quarter-end June 30, 2026. The largest holdings include Pharvaris N.V., CYTOKINETICS INC, and Relay Therapeutics, Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 6
- Portfolio Value
- $290.15M
Holdings by Sector
Foresite Capital Management Iv, Llc Portfolio Holdings in Q2 2026
5 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Pharvaris N.V. | PHVS | Other | 56.95% | 4,778,581 | - | - | $165,243,331 |
| CYTOKINETICS INC | CYTK | Healthcare | 20.98% | 714,695 | +211,400 | +42.00% | $60,884,867 |
| Relay Therapeutics, Inc. | RLAY | Healthcare | 8.06% | 1,250,000 | +250,000 | +25.00% | $23,387,500 |
| Xenon Pharmaceuticals Inc. | XENE | Healthcare | 3.33% | 160,000 | - | - | $9,657,600 |
| Crinetics Pharmaceuticals, Inc. | CRNX | Healthcare | 1.93% | 150,000 | +150,000 | +100.00% | $5,613,000 |